BrainLife
Library
CNS Tumors
Tumors of the sellar region


Home > Library > CNS Tumors > Tumors of the sellar region


CONTENTS



TUMOR GROUP
CASE REPORTS
CLASSIFICATION
DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS
ETIOLOGY, PATHOGENESIS, PATHOLOGY
FOLLOW-UP, QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT




GROUP COMPONENTS


CRANIOPHARYNGIOMA



Tumor Group




Follow-up, Side effects, Quality of life




TOXICITY AND SIDE EFFECTS



Burman P, van Beek AP, Biller BM, Camacho-Hübner C, Mattsson AF.
Radiotherapy, Especially at Young Age, Increases the Risk for De Novo Brain Tumors in Patients Treated for Pituitary/Sellar Lesions.
J Clin Endocrinol Metab. [2017 Jan 13]. 2017;102(3):1051-1058. Doi 10.1210/jc.2016-3402. _



Overall management




Review

Schwetye KE, Dahiya SM.
Sellar Tumors.
Surg Pathol Clin. [2020 May 7]. 2020;13(2):305-329. doi: 10.1016/j.path.2020.02.006. _


Sellar region lesions include a broad range of benign and malignant neoplastic as well as non-neoplastic entities, many of which are newly described or have recently revised nomenclature. In contrast to other intracranial sites, imaging features are relatively less specific, and the need for histopathological diagnosis is of paramount importance. This review will describe pituitary adenomas, inflammatory lesions, and tumors unique to the region (craniopharyngioma) as well as tumors which may occur in but are not exclusively localized to the sellar location (schwannoma, metastasis, etc.).